Bastos-Oreiro M, de las Heras A, Presa M, Casado MA, Pardo C, Martín-Escudero V, Sureda A Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs Tisagenlecleucel for the Management of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Spain Cancers 2022; 14(3), 538 MÁS INFORMACIÓN